Millions of Americans over the age of 65 lack access to the social and emotional support they need for healthy aging, according to the Centers for Disease Control and Prevention.
GSK’s asthma blockbuster Nucala secures win in COPD Phase III trial – Pharmaceutical Technology
GSK anticipates regulatory submission for Europe and Canada in 2025, as per a previous earnings report. Image credit: Shutterstock / OleksSH. GSK’s asthma drug Nucala